Blast Phase in Chronic Myelogenous Leukemia Is Skewed Toward Unusual Blast Types in Patients Treated With Tyrosine Kinase Inhibitors
Open Access
- 1 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 143 (1) , 105-119
Abstract
Objectives:. To compare the features of the blast phase of chronic myelogenous leukemia (CML) in patients treated with tyrosine kinase inhibitors (TKIsKeywords
This publication has 31 references indexed in Scilit:
- Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domainBlood, 2013
- NF‐κB subunit specificity in hemopoiesisImmunological Reviews, 2012
- BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcriptionBlood, 2011
- Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specificationBlood, 2011
- The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray dataBlood, 2009
- IL-3 Induces Basophil Expansion In Vivo by Directing Granulocyte-Monocyte Progenitors to Differentiate into Basophil Lineage-Restricted Progenitors in the Bone Marrow and by Increasing the Number of Basophil/Mast Cell Progenitors in the SpleenThe Journal of Immunology, 2009
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of CancerJournal of Clinical Pathology, 2006
- Immunophenotype and Ultrastructural Studies in Blast Crisis of Chronic Myeloid LeukemiaLeukemia & Lymphoma, 1995
- Lymphoid Blast Crises of Chronic Myelogenous Leukemia Represent Stages in the Development of B-Cell PrecursorsNew England Journal of Medicine, 1983